A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
Public ClinicalTrials.gov record NCT06873789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Open-Label, Multicenter Study of INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be conducted to evaluate INCB177054 given as monotherapy or in combination with retifanlimab in participants with select advanced or metastatic solid Tumors.
Study identification
- NCT ID
- NCT06873789
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 9 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2025 (Actual)
- Primary completion
- Jul 29, 2026 (Actual)
- Completion
- Jul 29, 2026 (Actual)
- Last update posted
- Sep 2, 2026
2025 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Angeles Clinic and Research Institute | Los Angeles | California | 90025 | — |
| Valkyrie Clinical Trials | Panorama City | California | 91402 | — |
| University of Florida Health Shands Hospital | Gainesville | Florida | 32610 | — |
| Cancer and Hematology Centers of Western Michigan-Start Midwest | Grand Rapids | Michigan | 49546 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Carolina Bio Oncology | Huntersville | North Carolina | 28078 | — |
| Providence Cancer Institute Franz Clinic | Portland | Oregon | 97213 | — |
| Upmc Cancercenter | Pittsburgh | Pennsylvania | 15232 | — |
| South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06873789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06873789 live on ClinicalTrials.gov.